0001415889-22-002868.txt : 20220310
0001415889-22-002868.hdr.sgml : 20220310
20220310204606
ACCESSION NUMBER: 0001415889-22-002868
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220308
FILED AS OF DATE: 20220310
DATE AS OF CHANGE: 20220310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Englese Thomas
CENTRAL INDEX KEY: 0001825799
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39577
FILM NUMBER: 22730896
MAIL ADDRESS:
STREET 1: C/O AZIYO BIOLOGICS, INC.
STREET 2: 12510 PROSPERITY DRIVE, SUITE 370
CITY: SILVER SPRING
STATE: MD
ZIP: 20904
FORMER NAME:
FORMER CONFORMED NAME: Englese Tom
DATE OF NAME CHANGE: 20200923
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AZIYO BIOLOGICS, INC.
CENTRAL INDEX KEY: 0001708527
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 474790334
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12510 PROSPERITY DRIVE
STREET 2: SUITE 370
CITY: SILVER SPRING
STATE: MD
ZIP: 20904
BUSINESS PHONE: 240-247-1143
MAIL ADDRESS:
STREET 1: 12510 PROSPERITY DRIVE
STREET 2: SUITE 370
CITY: SILVER SPRING
STATE: MD
ZIP: 20904
4
1
form4-03102022_050356.xml
X0306
4
2022-03-08
0001708527
AZIYO BIOLOGICS, INC.
AZYO
0001825799
Englese Thomas
C/O AZIYO BIOLOGICS, INC.
12510 PROSPERITY DRIVE, SUITE 370
SILVER SPRING
MD
20904
false
true
false
false
CHIEF COMMERCIAL OFFICER
Class A Common Stock
2022-03-08
4
M
0
938
0
A
6883
D
Class A Common Stock
2022-03-10
4
S
0
276
D
6607
D
Stock Option (Right to Buy)
5.08
2022-03-08
4
A
0
31000
0
A
2032-03-08
Class A Common Stock
31000
31000
D
Restricted Stock Units
2022-03-08
4
A
0
8700
0
A
Class A Common Stock
8700
8700
D
Restricted Stock Units
2022-03-08
4
M
0
938
0
D
Class A Common Stock
938
2812
D
Restricted Stock Units
2022-03-08
4
A
0
15390
0
A
Class A Common Stock
15390
15390
D
Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis.
Includes 857 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.16 to $5.34. The Reporting Person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The option vests as to 25% of the shares on March 8, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2026.
Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock.
The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024.
On March 8, 2021, the Reporting Person was granted 3,750 restricted stock units, vesting in four substantially equal annual installments beginning in March 8, 2022.
The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date.
/s/ Jeffrey Hamet, Attorney-in-Fact for Thomas Englese
2022-03-10